Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Desoximetasone
Drug ID BADD_D00620
Description A topical anti-inflammatory glucocorticoid used in dermatoses, skin allergies, psoriasis, etc.
Indications and Usage For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Marketing Status Prescription; Discontinued
ATC Code D07AC03; D07XC02
DrugBank ID DB00547
KEGG ID D03697
MeSH ID D003899
PubChem ID 5311067
TTD Drug ID D0CZ1Q
NDC Product Code 68788-7703; 50090-3919; 51672-5204; 51927-0187; 68180-946; 0472-0479; 51672-1396; 0168-0180; 51672-1261; 51672-1270; 51672-5203; 68382-889; 51672-1262; 68788-7695; 70771-1437; 68180-944; 0472-0478; 45802-807; 68180-948; 68180-949; 51672-1271; 0168-0151; 0713-0657; 71205-271; 51672-1352; 63629-8702; 52565-030; 51672-5202; 68180-950; 70771-1166; 51672-5281; 45802-496; 72578-095; 52565-045; 68462-531; 22552-0008; 50090-5571; 63629-8642; 53002-9280; 64980-326; 63187-646; 45802-495; 40032-024; 50090-0597; 64980-327; 72578-091; 63629-8641; 82298-112; 51672-5205; 46439-8706; 51672-5263
Synonyms Desoximetasone | Desoxymethasone | 17-Desoxymethasone | 17 Desoxymethasone | Deoxydexamethasone | Topicort | Stiedex | A-41304 | A 41304 | A41304 | Ibaril | Topisolon | Flubason | Topicorte | Desoxi
Chemical Information
Molecular Formula C22H29FO4
CAS Registry Number 140218-14-0
SMILES CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)F)C
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acne23.02.01.001--Not Available
Application site irritation08.02.01.003; 12.07.01.003--Not Available
Application site pruritus08.02.01.005; 12.07.01.005; 23.03.12.004--Not Available
Burning sensation08.01.09.029; 17.02.06.001--Not Available
Cataract subcapsular06.06.01.002--Not Available
Cushing's syndrome05.01.01.001; 14.11.01.007; 19.07.03.002; 24.08.04.001--Not Available
Dermatitis23.03.04.002--Not Available
Dermatitis acneiform23.02.01.004--
Dermatitis contact10.01.01.003; 12.03.01.040; 23.03.04.004--Not Available
Dermatitis infected11.01.12.011; 23.03.04.024--Not Available
Dry skin23.03.03.001--
Erythema23.03.06.001--Not Available
Folliculitis11.01.12.018; 23.09.04.007--
Glycosuria20.02.01.005--
Hyperglycaemia05.06.02.002; 14.06.02.002--
Hypertrichosis23.02.04.002--
Infection11.01.08.002--Not Available
Leukoderma23.05.02.001--Not Available
Miliaria23.02.03.014--Not Available
Pain08.01.08.004--
Pruritus23.03.12.001--
Psoriasis10.02.01.036; 23.03.14.002--Not Available
Pyoderma11.01.12.009; 23.09.01.007--Not Available
Secondary adrenocortical insufficiency05.01.02.003; 14.11.01.014--Not Available
Skin atrophy23.01.05.001--
Skin hypopigmentation23.05.02.003--
Skin irritation23.03.04.009--Not Available
Skin striae23.01.05.002--Not Available
Telangiectasia23.06.03.001; 24.03.03.003--
Skin maceration23.03.03.016--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages